HSP70-DERIVED PEPTIDE, PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING CANCER USING SAME, IMMUNITY INDUCER, AND METHOD FOR PRODUCING ANTIGEN-PRESENTING CELL
- 专利权人:
- CYTLIMIC INC.
- 发明人:
- Tomoya Miyakawa,Masaaki OKA,Shoichi HAZAMA,Koji TAMADA,Keiko UDAKA
- 申请号：
- US16715758
- 公开号：
- US20200121772A1
- 申请日:
- 2019.12.16
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- The present invention provides a peptide containing 8 or more consecutive amino acid residues in an amino acid sequence of any of SEQ ID NOS: 1 to 15 and consisting of 11 or less amino acid residues.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- HSP70-Derived Peptide, Pharmaceutical Composition for Treating or Preventing Cancer Using Same, Immunity Inducer, and Method for Producing Antigen Presenting Cell
- HSP70-derived peptide, and method of manufacturing pharmaceutical composition, immunity inducer, and antigen-presenting cell for cancer treatment or prevention using the same
- hsp70-derived peptide, pharmaceutical composition for treating or preventing cancer using the same, immunity inducer and antigen presenting cell production method
- HSP70 DERIVED PEPTIDE AND METHOD OF MANUFACTURING PHARMACEUTICAL COMPOSITION IMMUNITY INDUCER AND ANTIGEN PRESENTING CELL FOR CANCER TREATMENT OR PREVENTION USING THE SAME
- Compounds for treating proliferative disorders
